Business Description
Founded in 2008 and based in York, UK, Aptamer Group develops and supplies specialized molecules called aptamers that can be designed to attach to specific biological targets. These molecules serve a wide range of industries, from drug development and medical testing to cosmetics and consumer health products. The company works with major organizations including AstraZeneca, Unilever, and several academic institutions, selling its solutions to clients across Europe, the United States, and beyond.